Search KNSA
Kiniksa Pharmaceuticals International, plc
Nasdaq · CIK 1730430
Last close75.79
Daily change+0.57 (0.76%)
10 Years gain+290.47%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
KNSA · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
78.3Momentum
100.0Acceleration
100.0Confidence
74.0Annual Revenue5
Quarterly Revenue15
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality14.4 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.9276 percentage points.
Operating leverageOperating margin improved by 22.7011 percentage points.
ROIC expansionROIC improved by 44.5553 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 14.8941%.
Key Metrics
Revenue Growth TTM87.55%OK
Revenue CAGR 3Y45.45%OK
Gross Margin88.76%OK
Operating Margin12.57%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC33.9%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y14.89%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $677.56M | $599.89M | $77.22M | $137.99M | $136.42M | 88.54% | 11.4% | 20.13% | 29.44% | 78.98M |
| 2025 FY Dec 31, 2024 | $423.24M | $362.33M | -$45.62M | $25.69M | $25.41M | 85.61% | -10.78% | 6% | -16.87% | 71.42M |
| 2025 FY Dec 31, 2023 | $270.26M | $236.85M | -$25.20M | $13.30M | $13.17M | 87.64% | -9.32% | 4.87% | -9.09% | 71.92M |
| 2024 FY Dec 31, 2022 | $220.18M | $197.29M | $9.77M | $5.81M | $5.70M | 89.6% | 4.44% | 2.59% | 6.1% | 70.42M |
| 2023 FY Dec 31, 2021 | $38.54M | $28.61M | -$156.64M | -$126.30M | -$126.71M | 74.22% | -406.38% | -328.75% | n/a | 68.58M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $689.70M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-050359, 0001558370-25-009738 |
| Revenue Growth TTM | 87.55% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-050359, 0001558370-25-009738 |
| Revenue CAGR 3Y | 45.45% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-019168 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001104659-26-019168 |
| Gross Profit CAGR 3Y | 44.87% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-019168 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001104659-26-050359, 0001558370-25-009738 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 88.76% | Gross Profit / Revenue | OK | 0001104659-26-050359, 0001558370-25-009738 |
| Operating Margin | 12.57% | Operating Income / Revenue | OK | 0001104659-26-050359, 0001558370-25-009738 |
| ROIC | 33.9% | NOPAT / Average Invested Capital | OK | 0001104659-26-050359, 0001558370-25-009738 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-050359 |
| Current Ratio | 3.79x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $8.37 | Revenue / Diluted Shares | OK | 0001104659-26-050359, 0001558370-25-009738 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |